Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. (KYTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KYTX · as of Jun 8, 2026
Key Statistics
Explore Kyverna Therapeutics, Inc. Data
kytx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
The KYTX analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $30.75, representing +311.65% upside from the current price of $7.47.
Competitors & Peers
kytx competitorsKYTX
ALLO
AVIR
CABA
CAPR
CTNMStock Performance
Full HistoryAbout Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients suffering from autoimmune diseases. Its lead product candidate is KYV-101, an …
what is kyverna therapeutics, inc. · kytx stock overview · kyverna therapeutics, inc. company profile · who is kyverna therapeutics, inc. ceo · kytx NASDAQ · kyverna therapeutics, inc. headquarters · kyverna therapeutics, inc. business segments
About Stock Overview & Key Data
Kyverna Therapeutics, Inc. (KYTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 9, 2024. As of the latest trading session, KYTX stock price is $7.47, with a market capitalization of $327.1M. The stock has returned +116.52% over the past 12 months and -20.53% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Kyverna Therapeutics, Inc. stock is Buy, with an average 12-month price target of $30.75. In fiscal year 2025, Kyverna Therapeutics, Inc. reported revenue of — and net income of -$161.3M. For detailed data — including Kyverna Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Kyverna Therapeutics, Inc. (KYTX) stock price is $7.47. The stock is traded on NASDAQ under the ticker symbol KYTX. The 52-week range is $2.52 – $13.67.